Thank you to our speakers, sponsors, and delegates who joined us in 2023 for the summit!
Integrate Advanced Biomarker Assessment of Neurodegeneration & Neuroinflammation to More Sensitively Translate CNS Drugs
Welcome to the Fluid & Imaging Biomarkers in Neuroscience Summit
The First Industry Forum for Translational Experts, Neuroscience Drug Sponsors & Biomarker Technology Developers to Transform Earlier Assessment of AD, PD, ALS & MS
Development and integration of validated, inexpensive, non-invasive, and reliable fluid and imaging biomarkers are critical to advance neurodegenerative and neuro-immunological drug candidates through clinical trials.
Built to provide cutting-edge insights across emerging biomarker technologies and address the current translational bottleneck hindering your pipeline’s success: the inaugural Fluid & Imaging Biomarkers in Neuroscience Summit was an unrivaled new opportunity to evaluate the latest biomarker research across AD, PD, MS & ALS, in one highly focused forum.
Translational experts and biomarker specialists from companies like Biogen, Eli Lilly, and Janssen united to engage in forward-thinking discussions to meaningfully advance biomarker assessments of neurodegenerative and neuroinflammatory disease-modifying therapeutics.
The 2023 World-Class Speaker Faculty Included:
Director, Data Science, Neuropsychiatry
Head of Fluid Biomarkers
Professor & Chief Physician
University of Gothenburg
”This meeting is a great opportunity to come together and discuss how we can support the clinical research moving forward with biomarkers in neurodegeneration, I very much look forward to the event!”
Kira Holmstrom Head of Biomarker Research Herantis Pharma
“This is an incredible opportunity to gain insight from academic and pharma leaders in the rapidly advancing field of fluid and imaging biomarkers in neuroscience”
Olga Kahn, Biomarker Scientist, Alector
“This is a great opportunity for researchers, biomarker developers and Pharma to connect and discuss fluid and imaging biomarkers in Neuroscience.”
Fan Liao Principal Research Scientist AbbVie